These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2889758)

  • 1. The Thrombolysis in Myocardial Infarction (TIMI) phase II pilot study: tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty.
    Passamani E; Hodges M; Herman M; Grose R; Chaitman B; Rogers W; Forman S; Terrin M; Knatterud G; Robertson T
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):51B-64B. PubMed ID: 2889758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial.
    TIMI Study Group
    N Engl J Med; 1989 Mar; 320(10):618-27. PubMed ID: 2563896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variables predictive of good functional outcome following thrombolytic therapy in the Thrombolysis in Myocardial Infarction phase II (TIMI II) pilot study.
    Rogers WJ; Bourge RC; Papapietro SE; Wackers FJ; Zaret BL; Forman S; Dodge HT; Robertson TL; Passamani ER; Braunwald E
    Am J Cardiol; 1989 Mar; 63(9):503-12. PubMed ID: 2521976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary angioplasty after recombinant tissue-type plasminogen activator in acute myocardial infarction: a report from the Thrombolysis in Myocardial Infarction (TIMI) Trial.
    Williams DO; Ruocco NA; Forman S
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):45B-50B. PubMed ID: 2959715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty: one-year TIMI phase II pilot results. TIMI Investigators.
    Chaitman BR; Thompson BW; Kern MJ; Vandormael MG; Cohen MB; Ruocco NA; Solomon RE; Braunwald E
    Am Heart J; 1990 Feb; 119(2 Pt 1):213-23. PubMed ID: 2105625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) trial.
    Topol EJ; Califf RM; Kereiakes DJ; George BS
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):65B-74B. PubMed ID: 2959716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group.
    JAMA; 1988 Nov; 260(19):2849-58. PubMed ID: 2972848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial.
    Ross AM; Coyne KS; Reiner JS; Greenhouse SW; Fink C; Frey A; Moreyra E; Traboulsi M; Racine N; Riba AL; Thompson MA; Rohrbeck S; Lundergan CF
    J Am Coll Cardiol; 1999 Dec; 34(7):1954-62. PubMed ID: 10588209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A matched comparison of the combination of prehospital thrombolysis and standby rescue angioplasty with primary angioplasty.
    Juliard JM; Himbert D; Cristofini P; Desportes JC; Magne M; Golmard JL; Aubry P; Benamer H; Boccara A; Karrillon GJ; Steg PG
    Am J Cardiol; 1999 Feb; 83(3):305-10. PubMed ID: 10072213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial.
    Dalen JE; Gore JM; Braunwald E; Borer J; Goldberg RJ; Passamani ER; Forman S; Knatterud G
    Am J Cardiol; 1988 Aug; 62(4):179-85. PubMed ID: 3135737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.
    Cannon CP; McCabe CH; Henry TD; Schweiger MJ; Gibson RS; Mueller HS; Becker RC; Kleiman NS; Haugland JM; Anderson JL
    J Am Coll Cardiol; 1994 Apr; 23(5):993-1003. PubMed ID: 8144799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
    Lincoff AM; Topol EJ; Califf RM; Sigmon KN; Lee KL; Ohman EM; Rosenschein U; Ellis SG
    Am J Cardiol; 1995 May; 75(14):871-6. PubMed ID: 7732992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The European Cooperative Study Group trial of intravenous recombinant tissue-type plasminogen activator (rt-PA) and conservative therapy versus rt-PA and immediate coronary angioplasty.
    de Bono DP
    J Am Coll Cardiol; 1988 Dec; 12(6 Suppl A):20A-23A. PubMed ID: 2973485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolysis and percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction.
    Zeymer U; Neuhaus KL
    Z Kardiol; 2000; 89 Suppl 4():IV30-40. PubMed ID: 10810775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Status of the myocardium and infarct-related coronary artery in 19 necropsy patients with acute recanalization using pharmacologic (streptokinase, r-tissue plasminogen activator), mechanical (percutaneous transluminal coronary angioplasty) or combined types of reperfusion therapy.
    Waller BF; Rothbaum DA; Pinkerton CA; Cowley MJ; Linnemeier TJ; Orr C; Irons M; Helmuth RA; Wills ER; Aust C
    J Am Coll Cardiol; 1987 Apr; 9(4):785-801. PubMed ID: 2951422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly: results from thrombolysis in myocardial infarction Phase I, open label studies and the Thrombolysis in Myocardial Infarction Phase II pilot study. The TIMI Investigators.
    Chaitman BR; Thompson B; Wittry MD; Stump D; Hamilton WP; Hillis LD; Dwyer JG; Solomon RE; Knatterud GL
    J Am Coll Cardiol; 1989 Nov; 14(5):1159-65. PubMed ID: 2509528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolysis in myocardial infarction (TIMI): update 1987.
    Mueller HS
    Klin Wochenschr; 1988; 66 Suppl 12():93-101. PubMed ID: 3126350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators.
    Rogers WJ; Babb JD; Baim DS; Chesebro JH; Gore JM; Roberts R; Williams DO; Frederick M; Passamani ER; Braunwald E
    J Am Coll Cardiol; 1991 Apr; 17(5):1007-16. PubMed ID: 1901071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial.
    Bovill EG; Terrin ML; Stump DC; Berke AD; Frederick M; Collen D; Feit F; Gore JM; Hillis LD; Lambrew CT
    Ann Intern Med; 1991 Aug; 115(4):256-65. PubMed ID: 1906692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of primary angioplasty with stent implantation and thrombolysis in restoring basal coronary artery flow in acute ST segment elevation myocardial infarction: quantitative assessment using the corrected TIMI frame count.
    Vrachatis AD; Alpert MA; Georgulas VP; Nikas DJ; Petropoulou EN; Lazaros GI; Michelakakis NA; Karavidis AI; Lakoumentas JA; Stergiou L; Zacharoulis AA
    Angiology; 2001 Mar; 52(3):161-6. PubMed ID: 11269778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.